2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine
2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine
amphetamine.svg)
2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine (also known as DOEF) is a psychedelic amphetamine of the substituted amphetamine class. It is a derivative of the phenethylamine 2C-E, with a fluorine atom replacing the ethyl group at the 4-position of the aromatic ring.
Chemical Structure
2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine is a member of the substituted amphetamines, which are characterized by the presence of a phenethylamine core with an alpha-methyl group. The chemical structure of DOEF includes two methoxy groups at the 2 and 5 positions of the aromatic ring, and a 2-fluoroethyl group at the 4 position.
Pharmacology
DOEF acts as a serotonin receptor agonist, primarily affecting the 5-HT2A receptor. This action is responsible for its psychedelic effects. The compound is structurally similar to other psychedelic amphetamines such as DOM and DOI, which are known for their potent hallucinogenic properties.
Effects
The effects of 2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine are similar to those of other psychedelic amphetamines. Users report altered states of consciousness, visual and auditory hallucinations, and changes in perception of time and space. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Synthesis
The synthesis of DOEF involves the introduction of a 2-fluoroethyl group to the 4-position of the aromatic ring of 2,5-dimethoxyamphetamine. This is typically achieved through a series of chemical reactions starting from 2,5-dimethoxybenzaldehyde.
Legal Status
The legal status of 2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine varies by country. In many jurisdictions, it is considered a controlled substance due to its structural similarity to other regulated psychedelic compounds.
Related Compounds
- 2,5-Dimethoxy-4-ethylamphetamine (DOET)
- 2,5-Dimethoxy-4-iodoamphetamine (DOI)
- 2,5-Dimethoxy-4-methylamphetamine (DOM)
- 2C-E
See Also
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
